Yann Godfrin

Yann Godfrin was the founder of ERYTech Pharma SA, founded in 2004, where the title held was Director & Chief Scientific Officer from 2015 to 2016.
Current jobs include Chief Executive Officer at NEURONAX SA and Chief Executive Officer at Axoltis Pharma SA. Memberships are held at the American Association of Blood Banks, International Society for Cellular Therapy, American Society of Hematology, European Association For Cancer Research, The French Society of Blood Transfusion Association, and Member-Supervisory Board at Nodea Medical SA. Education history includes undergraduate studies at Université de Technologie de Compiègne, graduate studies at the University of Lyon, and a doctorate from the University of Nantes.